Nevro Introduces HFX, New Comprehensive Brand Identity Combining Nevro's Innovative Technologies, Advanced Therapies and End-To-End Patient Support
April 26, 2021 at 08:45 am EDT
Share
Nevro Corp. announced the introduction of its new HFX brand and updated website, which is designed to unify its products and services to optimize the physician and patient experience. The introduction of the HFX brand platform includes the full U.S. market launch of the company's recent Omnia upgrade (powered by HFX Connect) and additional patient support resources (HFX Coach™, formerly called Therapy Support Specialists) who are trained in remote therapy optimization. HFX gives Nevro the ability to bring together its innovative technologies, advanced therapies and end-to-end support services, all of which are built on an foundation of robust clinical data. For physicians, HFX technologies and advanced therapies offer the broadest range of frequencies and waveforms, including Nevro's proprietary 10 kHz therapy, which has demonstrated superior back and leg pain relief versus traditional spinal cord stimulation (SCS) and is the most studied waveform in the industry. HFX Connect: Continuing Innovation for Individualized Therapy and Patient Support- Omnia powered by HFX Connect, provides the widest array of SCS frequencies and waveforms, which can now also be delivered remotely by HFX Coaches to meet every patient's needs. HFX Connect is universally compatible with both new and previously implanted Omnia systems; HFX Connect enables remote patient therapy optimization that leverages a data-driven programming approach informed by over 70,000 patient outcomes. With 7x more programming capacity, the system now delivers more versatility and therapy optimization without in-person visits; Exclusive HFX Cloud™ enables real-time, data-informed patient care by tracking and sharing each patient's specific therapy outcomes with the patient's physician and HFX support team; Dedicated HFX Coaches provide remote, individualized patient therapy support, from pre-trial education to long-term success. In addition to existing Nevro in-person representatives, HFX Coaches deliver an number of proactive and on-demand patient touchpoints; Remote system diagnostics, available to both Omnia and legacy Nevro SCS patients, allow health care providers to more efficiently evaluate systems and facilitate MRI scans. All new Omnia implants include HFX Connect, and the company plans to upgrade the majority of existing Omnia devices by the end of 2021. The company expects full market release of Omnia powered by HFX Connect in Australia later next month and regulatory approval in Europe later this year.
Nevro Corp. is a global medical device company. The Company is focused on delivering solutions that continue to set the standard for enduring patient outcomes in chronic pain treatment. Its comprehensive HFX spinal cord stimulation 3 (SCS) platform includes the Senza SCS system and support services for the treatment of chronic pain of the trunk and limb and painful diabetic neuropathy. It has developed and commercialized its HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the treatment of chronic pain, with the Senza HFX iQ platform. Its HFX solution delivers a range of waveforms, including its paresthesia-free 10 kHz Therapy. Its 10 kHz Therapy is designed to deliver neuromodulation solutions for treating chronic pain. Its products include Senza II SCS System, Senza Omnia SCS System, Senza Omnia upgrade, Omnia Powered by HFX Connect, Senza HFX iQ System, and Surpass Surgical Lead.